Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

A Phase 1/2 Study of Favezelimab in Combination with Pembrolizumab for Anti–pd-1–Naive Relapsed or Refractory (R/R) Classical Hodgkin Lymphoma (chl): an Updated Analysis.

John Timmerman,David Lavie,Borchmann Peter,Gareth P. Gregory,Alex Francisco Herrera,Leonard Minuk,Vladan Vucinic,Philippe Armand,Abraham Avigdor,Robin Gasiorowski,Yair Herishanu,Colm Keane,John Kuruvilla,Rachel Marceau West,Pallavi Pillai,Patricia Marinello,Nathalie A. Johnson

Journal of Clinical Oncology（2024）

Cited 0|Views6

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined